Literature DB >> 60174

Single-strand scission and repair of DNA in mammalian cells by bleomycin.

Z M Iqbal, K W Kohn, R A Ewig, A J Fornace.   

Abstract

DNA single-strand breakage by bleomycin treatment of cultured mammalian cells was demonstrated by the method of alkaline elution. Elution patterns from treated L1210 cells indicated that part of the DNA was extensively broken while the remainder was affected to a lesser degree. This biphasic effect, which was less prominent in human fibroblasts, may reflect a selective sensitivity either of part of the cell population or of part of the DNA within individual cells. In both cell types, the DNA damage was at least partially repaired upon incubation of the cells after removal of drug. Bleomycin did not inhibit the rejoining of X-ray-induced single-strand breaks. The production and repair of DNA single-strand breaks after bleomycin treatment were the same in normal human and xeroderma pigmentosum fibroblasts, indicating that these events do not require the excision endonuclease that appears to be defective in these ultraviolet light-sensitive xeroderma cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 60174

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  X-ray induced DNA double strand break production and repair in mammalian cells as measured by neutral filter elution.

Authors:  M O Bradley; K W Kohn
Journal:  Nucleic Acids Res       Date:  1979-10-10       Impact factor: 16.971

2.  Augmentation of fibroblast proliferation by bleomycin.

Authors:  P L Moseley; C Hemken; G W Hunninghake
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

3.  Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition.

Authors:  Alexander Koshkaryev; Aleksandr Piroyan; Vladimir P Torchilin
Journal:  Cancer Lett       Date:  2012-06-25       Impact factor: 8.679

Review 4.  Mutagenic effects of some anticancer antibiotics.

Authors:  B K Vig
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

5.  High-performance liquid chromatography assay of bleomycin in human plasma and rat hepatocytes in culture.

Authors:  R Mahdadi; A Kenani; N Pommery; J Pommery; J P Hénichart; M Lhermitte
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

6.  Lesions and preferential initial localization of [S-methyl-3H]bleomycin A2 on Saccharomyces cerevisiae cell walls and membranes.

Authors:  C W Moore; R Del Valle; J McKoy; A Pramanik; R E Gordon
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

7.  Structure-activity relationships involved in the site-specific fragmentation of linear duplex DNAs by talisomycin and bleomycin analogs.

Authors:  C K Mirabelli; C H Huang; A W Prestayko; S T Crooke
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

8.  Bleomycin-induced injury and metaplasia of alveolar type 2 cells. Relationship of cellular responses to drug presence in the lung.

Authors:  I Y Adamson; D H Bowden
Journal:  Am J Pathol       Date:  1979-08       Impact factor: 4.307

9.  Origin of ciliated alveolar epithelial cells in bleomycin-induced lung injury.

Authors:  I Y Adamson; D H Bowden
Journal:  Am J Pathol       Date:  1977-06       Impact factor: 4.307

10.  Biological and biochemical activities of the novel antitumor antibiotic PD 114,759 and related derivatives.

Authors:  D W Fry; J L Shillis; W R Leopold
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.